However, recent reports suggest that cancer-associated fibroblasts (CAFs), macrophage type 2 (M2) cells, and regulatory T-cells (Tregs) form immunologic barriers to CD8+ T-cell-mediated anti-tumor immune responses [87]. This evidence concerns the gene CD8A and neoplasm.